Symbols / BTCY
BTCY Chart
About
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux and Biocore Pro, an integrated ECG device and software that utilizes wet electrodes for cardiac outpatient monitoring (COM) market; Biocore, a Holter and Extended Holter monitors for cardiac diagnostics; Biocare which support medical practitioners to gather data, and regularly monitor and treat patients with two or more chronic care conditions; Bioheart that offers preventative care and disease management solutions; and Biokit, a remote patient monitoring kit for cardiac patients that had other chronic conditions such as hypertension or COPD. Biotricity, Inc. is based in Redwood City, California.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Devices | Market Cap | 8.01M |
| Enterprise Value | 36.84M | Income | -4.70M | Sales | 15.45M |
| Book/sh | -1.22 | Cash/sh | 0.05 | Dividend Yield | — |
| Payout | 0.00% | Employees | 46 | IPO | — |
| P/E | — | Forward P/E | -0.65 | PEG | — |
| P/S | 0.52 | P/B | -0.23 | P/C | — |
| EV/EBITDA | 250.30 | EV/Sales | 2.38 | Quick Ratio | 0.13 |
| Current Ratio | 0.21 | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | -0.16 | EPS next Y | -0.43 | EPS Growth | — |
| Revenue Growth | 10.20% | Earnings | 2026-02-11 | ROA | 1.51% |
| ROE | — | ROIC | — | Gross Margin | 81.09% |
| Oper. Margin | 11.06% | Profit Margin | -25.99% | Shs Outstand | 28.44M |
| Shs Float | 16.39M | Short Float | 2.25% | Short Ratio | 5.50 |
| Short Interest | — | 52W High | 0.83 | 52W Low | 0.20 |
| Beta | 1.37 | Avg Volume | 73.64K | Volume | 55.40K |
| Target Price | — | Recom | None | Prev Close | $0.26 |
| Price | $0.28 | Change | 8.59% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$0.28
Latest analyst target
3. DCF / Fair value
$0.24
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.28
Low
—
High
—
Mean
—
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2024-11-18 | reit | HC Wainwright & Co. | — → Neutral | — |
| 2023-11-20 | down | HC Wainwright & Co. | Buy → Neutral | — |
| 2023-07-05 | reit | HC Wainwright & Co. | Buy → Buy | $4 |
- (BTCY) Dynamic Trading Report (BTCY:CA) - Stock Traders Daily ue, 24 Feb 2026 13
- Biotricity (BTCY) Upgraded to Buy: Here's Why - Yahoo Finance Fri, 15 Aug 2025 07
- 3 Healthcare IT Stocks Up More Than 20% in 2025 With More Room to Run - The Globe and Mail ue, 23 Dec 2025 08
- Are Medical Stocks Lagging Biotricity (BTCY) This Year? - Yahoo Finance ue, 19 Aug 2025 07
- Biotricity Inc. (BTCY) Reports Q2 Loss, Lags Revenue Estimates - Nasdaq Fri, 14 Nov 2025 08
- Biotricity Recognized by Financial Times as One of 2025’s - GlobeNewswire ue, 08 Apr 2025 07
- Biotricity Strengthens its Foundation for Growth, Achieves Lower Cost of Sales, Expanding Margins of 73% and Increased Device Sales, for Third Quarter of Fiscal Year 2024 - Stock Titan Wed, 21 Feb 2024 08
- Biotricity faces potential nasdaq delisting over share price - Investing.com hu, 01 Aug 2024 07
- Biotricity - BTCY - Stock Price Today - Zacks Investment Research Fri, 10 Feb 2017 18
- Fate Therapeutics (FATE) Reports Q3 Loss, Beats Revenue Estimates - Nasdaq hu, 13 Nov 2025 08
- Biotricity Announces Reverse Stock Split - Yahoo Finance Fri, 30 Jun 2023 07
- Here’s a Bitcoin ETF That Pays an 11% Yield With Monthly Dividends - Yahoo! Finance Canada Wed, 28 May 2025 07
- (BTCY.B) Stock Market Analysis (BTCY.B:CA) - Stock Traders Daily Sun, 04 Jan 2026 08
- Purpose Bitcoin Yield ETF (BTCY-T) Stock Price and News - The Globe and Mail Mon, 06 Dec 2021 20
- Biotricity to Implement 1-for-6 Reverse Stock Split - marketscreener.com Fri, 30 Jun 2023 07
Insider Transactions
No recent insider transactions.
Financials
| Line Item | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -2.66M | -8.91M | -15.59M | -17.88M |
| TotalUnusualItems | -553.86K | 9.78K | -483.87K | -683.56K |
| TotalUnusualItemsExcludingGoodwill | -553.86K | 9.78K | -483.87K | -683.56K |
| NetIncomeFromContinuingOperationNetMinorityInterest | -8.42M | -14.09M | -18.66M | -29.13M |
| ReconciledDepreciation | 5.95K | 5.95K | 5.95K | 2.31K |
| ReconciledCostOfRevenue | 3.23M | 3.71M | 4.20M | 3.08M |
| EBITDA | -3.21M | -8.90M | -16.07M | -18.56M |
| EBIT | -3.22M | -8.90M | -16.08M | -18.56M |
| NetInterestIncome | -5.20M | -5.19M | -2.58M | -10.57M |
| InterestExpense | 5.20M | 5.19M | 2.58M | 10.57M |
| NormalizedIncome | -7.87M | -14.10M | -18.17M | -28.45M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -8.42M | -14.09M | -18.66M | -29.13M |
| TotalExpenses | 16.24M | 20.89M | 25.05M | 24.39M |
| TotalOperatingIncomeAsReported | -2.45M | -8.83M | -15.41M | |
| DilutedAverageShares | 21.52M | 8.99M | 8.66M | 7.57M |
| BasicAverageShares | 21.52M | 8.99M | 8.66M | 7.57M |
| DilutedEPS | -0.56 | -1.66 | -2.26 | -3.99 |
| BasicEPS | -0.56 | -1.66 | -2.26 | -3.99 |
| DilutedNIAvailtoComStockholders | -11.94M | -14.93M | -19.53M | -30.22M |
| NetIncomeCommonStockholders | -11.94M | -14.93M | -19.53M | -30.22M |
| OtherunderPreferredStockDividend | 3.05M | 0.00 | ||
| PreferredStockDividends | 466.14K | 834.68K | 875.54K | 1.09M |
| NetIncome | -8.42M | -14.09M | -18.66M | -29.13M |
| NetIncomeIncludingNoncontrollingInterests | -8.42M | -14.09M | -18.66M | -29.13M |
| NetIncomeContinuousOperations | -8.42M | -14.09M | -18.66M | -29.13M |
| TaxProvision | 0.00 | 0.00 | 0.00 | 0.00 |
| PretaxIncome | -8.42M | -14.09M | -18.66M | -29.13M |
| OtherIncomeExpense | -770.36K | -74.29K | -665.81K | -1.82M |
| OtherNonOperatingIncomeExpenses | -216.50K | -84.07K | -181.94K | -1.14M |
| GainOnSaleOfSecurity | -553.86K | 9.78K | -483.87K | -683.56K |
| NetNonOperatingInterestIncomeExpense | -5.20M | -5.19M | -2.58M | -10.57M |
| TotalOtherFinanceCost | 678.35K | |||
| InterestExpenseNonOperating | 5.20M | 5.19M | 2.58M | 10.57M |
| OperatingIncome | -2.45M | -8.83M | -15.41M | -16.74M |
| OperatingExpense | 13.01M | 17.18M | 20.85M | 21.31M |
| ResearchAndDevelopment | 2.16M | 2.57M | 3.23M | 2.74M |
| SellingGeneralAndAdministration | 10.86M | 14.61M | 17.62M | 18.56M |
| GeneralAndAdministrativeExpense | 10.86M | 14.61M | 17.62M | 18.56M |
| OtherGandA | 10.86M | 14.61M | 17.62M | 18.56M |
| GrossProfit | 10.56M | 8.36M | 5.44M | 4.57M |
| CostOfRevenue | 3.23M | 3.71M | 4.20M | 3.08M |
| TotalRevenue | 13.79M | 12.06M | 9.64M | 7.65M |
| OperatingRevenue | 13.79M | 12.06M | 9.64M | 7.65M |
| Line Item | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 26.24M | 9.51M | 8.75M | 8.55M |
| ShareIssued | 26.24M | 9.51M | 8.75M | 8.55M |
| NetDebt | 24.80M | 21.71M | 17.25M | 1.96M |
| TotalDebt | 26.09M | 23.88M | 19.55M | 15.35M |
| TangibleBookValue | -32.01M | -31.47M | -19.85M | -2.14M |
| InvestedCapital | -6.85M | -8.97M | -2.02M | 11.88M |
| WorkingCapital | -16.00M | -18.23M | -6.44M | 10.46M |
| NetTangibleAssets | -30.01M | -29.98M | -19.85M | -2.14M |
| CapitalLeaseObligations | 929.12K | 1.39M | 1.72M | 1.33M |
| CommonStockEquity | -32.01M | -31.47M | -19.85M | -2.14M |
| PreferredStockEquity | 2.00M | 1.49M | 7.00 | 8.00 |
| TotalCapitalization | -16.87M | -19.12M | -6.80M | 10.34M |
| TotalEquityGrossMinorityInterest | -30.01M | -29.98M | -19.85M | -2.14M |
| StockholdersEquity | -30.01M | -29.98M | -19.85M | -2.14M |
| OtherEquityInterest | 284.24K | 269.06K | 25.00K | 102.30K |
| GainsLossesNotAffectingRetainedEarnings | 145.79K | 32.38K | -152.80K | -768.66K |
| OtherEquityAdjustments | 145.79K | 32.38K | -152.80K | -768.66K |
| RetainedEarnings | -139.44M | -127.50M | -112.57M | -93.04M |
| AdditionalPaidInCapital | 106.97M | 95.72M | 92.84M | 91.51M |
| CapitalStock | 2.03M | 1.50M | 8.76K | 51.28K |
| CommonStock | 26.24K | 9.52K | 8.75K | 51.28K |
| PreferredStock | 2.00M | 1.49M | 7.00 | 8.00 |
| TotalLiabilitiesNetMinorityInterest | 35.66M | 35.92M | 26.36M | 18.82M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 15.02M | 13.22M | 15.20M | 13.96M |
| DerivativeProductLiabilities | 1.48M | 1.44M | 759.07K | 352.40K |
| LongTermDebtAndCapitalLeaseObligation | 13.54M | 11.78M | 14.44M | 13.60M |
| LongTermCapitalLeaseObligation | 397.83K | 929.12K | 1.39M | 1.12M |
| LongTermDebt | 13.14M | 10.86M | 13.05M | 12.48M |
| CurrentLiabilities | 20.64M | 22.70M | 11.16M | 4.87M |
| OtherCurrentLiabilities | 424.20K | 991.87K | 1.01M | 520.75K |
| CurrentDeferredLiabilities | 25.32K | 21.55K | 0.00 | |
| CurrentDeferredRevenue | 25.32K | 21.55K | 0.00 | |
| CurrentDebtAndCapitalLeaseObligation | 12.55M | 12.09M | 5.11M | 1.75M |
| CurrentCapitalLeaseObligation | 531.29K | 457.37K | 335.61K | 210.32K |
| CurrentDebt | 12.02M | 11.64M | 4.77M | 1.54M |
| OtherCurrentBorrowings | 12.02M | 11.64M | 4.77M | 1.54M |
| PayablesAndAccruedExpenses | 7.64M | 9.59M | 5.04M | 2.60M |
| CurrentAccruedExpenses | 3.03M | 4.37M | 1.61M | 1.44M |
| Payables | 4.60M | 5.22M | 3.44M | 1.16M |
| AccountsPayable | 4.60M | 5.22M | 3.44M | 1.16M |
| TotalAssets | 5.64M | 5.94M | 6.51M | 16.68M |
| TotalNonCurrentAssets | 1.00M | 1.47M | 1.79M | 1.36M |
| NonCurrentPrepaidAssets | 109.30K | 85.00K | 85.00K | 85.00K |
| NonCurrentAccountsReceivable | 70.71K | 149.91K | 96.34K | 50.36K |
| NetPPE | 821.65K | 1.24M | 1.61M | 1.27M |
| AccumulatedDepreciation | -20.17K | -14.21K | -8.26K | -2.31K |
| GrossPPE | 841.82K | 1.25M | 1.62M | 1.27M |
| Leases | 12.93K | 12.93K | 12.93K | 12.93K |
| OtherProperties | 812.05K | 1.22M | 1.59M | 1.24M |
| MachineryFurnitureEquipment | 16.84K | 16.84K | 16.84K | 16.84K |
| BuildingsAndImprovements | 413.24K | |||
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 4.64M | 4.47M | 4.72M | 15.32M |
| PrepaidAssets | 406.28K | 326.66K | ||
| Inventory | 1.56M | 1.88M | 2.34M | 842.92K |
| FinishedGoods | 329.72K | 750.70K | 1.15M | 374.47K |
| RawMaterials | 1.23M | 1.13M | 1.19M | 468.45K |
| Receivables | 2.72M | 1.81M | 1.81M | 2.41M |
| OtherReceivables | 1.06M | 336.46K | 588.60K | 406.28K |
| AccountsReceivable | 1.66M | 1.47M | 1.22M | 2.01M |
| CashCashEquivalentsAndShortTermInvestments | 365.14K | 786.06K | 570.46K | 12.07M |
| CashAndCashEquivalents | 365.14K | 786.06K | 570.46K | 12.07M |
| CashFinancial | 365.14K | 786.06K | 570.46K | 12.07M |
| Line Item | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| FreeCashFlow | -2.38M | -6.69M | -13.55M | -15.19M |
| RepurchaseOfCapitalStock | 0.00 | -895.56K | -230.00K | 0.00 |
| RepaymentOfDebt | -1.66M | -408.08K | ||
| IssuanceOfDebt | 1.83M | 2.96M | 2.36M | 12.26M |
| IssuanceOfCapitalStock | 1.86M | 2.94M | 0.00 | 14.90M |
| CapitalExpenditure | -29.77K | |||
| InterestPaidSupplementalData | 3.61M | 2.02M | 1.62M | 553.26K |
| IncomeTaxPaidSupplementalData | 0.00 | 0.00 | 0.00 | 0.00 |
| EndCashPosition | 365.14K | 786.06K | 570.46K | 12.07M |
| BeginningCashPosition | 786.06K | 570.46K | 12.07M | 2.20M |
| EffectOfExchangeRateChanges | 30.00K | 167.83K | 49.86K | -109.71K |
| ChangesInCash | -450.92K | 47.77K | -11.55M | 9.98M |
| FinancingCashFlow | 1.93M | 6.74M | 2.00M | 25.17M |
| CashFlowFromContinuingFinancingActivities | 1.93M | 6.74M | 2.00M | 25.17M |
| ProceedsFromStockOptionExercised | 0.00 | 12.50K | 872.29K | 67.94K |
| CashDividendsPaid | -29.98K | -18.02K | -946.78K | -966.11K |
| PreferredStockDividendPaid | -29.98K | -18.02K | -946.78K | -966.11K |
| NetPreferredStockIssuance | 1.73M | 2.83M | -895.56K | -130.00K |
| PreferredStockPayments | 0.00 | -895.56K | -230.00K | 0.00 |
| PreferredStockIssuance | 1.73M | 2.83M | 0.00 | 100.00K |
| NetCommonStockIssuance | 125.23K | 119.28K | 0.00 | 14.80M |
| CommonStockIssuance | 125.23K | 119.28K | 0.00 | 14.80M |
| NetIssuancePaymentsOfDebt | 101.48K | 3.82M | 3.83M | 10.60M |
| NetShortTermDebtIssuance | -1.73M | 853.03K | 1.48M | -1.66M |
| ShortTermDebtPayments | -1.66M | -408.08K | ||
| ShortTermDebtIssuance | 3.83M | 0.00 | 0.00 | |
| NetLongTermDebtIssuance | 1.83M | 2.96M | 2.36M | 12.26M |
| LongTermDebtIssuance | 1.83M | 2.96M | 2.36M | 12.26M |
| InvestingCashFlow | 0.00 | -29.77K | 0.00 | |
| CashFlowFromContinuingInvestingActivities | 0.00 | -29.77K | 0.00 | |
| NetPPEPurchaseAndSale | 0.00 | -29.77K | 0.00 | |
| PurchaseOfPPE | 0.00 | -29.77K | 0.00 | |
| OperatingCashFlow | -2.38M | -6.69M | -13.55M | -15.16M |
| CashFlowFromContinuingOperatingActivities | -2.38M | -6.69M | -13.55M | -15.16M |
| ChangeInWorkingCapital | 962.23K | 3.68M | 2.31M | -117.58K |
| ChangeInPayablesAndAccruedExpense | 1.50M | 3.27M | 3.34M | 949.00K |
| ChangeInPrepaidAssets | -747.83K | 252.14K | -224.82K | -60.66K |
| ChangeInInventory | 324.02K | 457.60K | -1.49M | -570.43K |
| ChangeInReceivables | -110.92K | -298.25K | 686.20K | -435.48K |
| ChangesInAccountReceivables | -110.92K | -298.25K | 686.20K | -435.48K |
| OtherNonCashItems | 3.06M | 2.70M | 1.66M | 12.49M |
| StockBasedCompensation | 1.46M | 1.03M | 647.63K | 913.61K |
| ProvisionandWriteOffofAssets | 103.73K | |||
| DepreciationAmortizationDepletion | 5.95K | 5.95K | 5.95K | 2.31K |
| DepreciationAndAmortization | 5.95K | 5.95K | 5.95K | 2.31K |
| Depreciation | 5.95K | 5.95K | 5.95K | 2.31K |
| OperatingGainsLosses | 553.86K | -9.78K | 483.87K | 683.56K |
| GainLossOnInvestmentSecurities | 553.86K | -9.78K | 483.87K | 683.56K |
| NetIncomeFromContinuingOperations | -8.42M | -14.09M | -18.66M | -29.13M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for BTCY
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|